Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook

Go back to Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook

Humana (HUM) PT Lowered to $353 at RBC Capital

April 25, 2024 6:44 AM EDT

RBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.

The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More

Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald

April 25, 2024 6:32 AM EDT

Cantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.

The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More

Humana (HUM) Tops Q1 EPS by 111c; reaffirms adjusted EPS outlook

April 24, 2024 6:33 AM EDT

Humana (NYSE: HUM) reported Q1 EPS of $7.23, $1.11 better than the analyst estimate of $6.12. Revenue for the quarter came in at $29.33 billion versus the consensus estimate of $28.52 billion.

GUIDANCE:

Humana sees FY2024 EPS of $16.00, versus the consensus of $16.36.

For earnings history and earnings-related data on Humana (HUM) click here.

... More